Interacting Drugs |
Etravirine vs Reverse Transcriptase Inhibitors (Non-Nucleoside) |
Security Level |
|
Mechanism |
Reverse Transcriptase Inhibitors (Non-Nucleoside): May decrease the serum concentration of Etravirine. This has been observed with the NNRTIs efavirenz and nevirapine. Reverse Transcriptase Inhibitors (Non-Nucleoside) may increase the serum concentration of Etravirine. This has been observed with delavirdine. |
Management |
Avoid combination |
Etravirine vs Reverse Transcriptase Inhibitors (Non-Nucleoside)
Post Review about Etravirine vs Reverse Transcriptase Inhibitors (Non-Nucleoside) Click here to cancel reply.
Other Interactions of Etravirine
Other Interactions of Reverse Transcriptase Inhibitors (Non-Nucleoside)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.